Drugs / AGSCT101
last change Sep 2012 re-read 2 minutes ago

AGSCT101

Developed for
essential hypertension
Investigated by
Ahn-Gook Pharmaceuticals Co.,Ltd

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01413048 Jan 2011 → Mar 2012 essential hypertension Ahn-Gook Pharmaceuticals Co.,Ltd Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AGSCT101 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01413048